Duchenne Muscular
Dystrophy:
a beginner’s guide to its
cause and potential treatments
What is Duchenne muscular dystrophy?
Duchenne
muscular dystrophy (DMD) is a progressive muscle wasting condition. It is relatively rare - roughly one in seven
thousand births – and affects mainly boys.
People
with DMD gradually lose strength in the skeletal muscles. Later the heart and respiratory muscles are
involved. DMD does not affect
continence, speech, or eye movements.
On
average boys with DMD begin to need a wheelchair full time between the ages of
eight and twelve.
Life
expectancy when DMD is untreated is around nineteen years. With specialist care management life
expectancy can rise into the thirties and even forties. Work being done on potential new treatments gives
realistic hope of even longer lives for the current generation of boys growing
up with DMD – the hope that DMD might become a long-term manageable condition.
What causes Duchenne muscular
dystrophy?
Lack of a
crucial protein called dystrophin:
In
order to work, our muscle cells need a protein called dystrophin.
Dystrophin
has two functions:
Firstly,
it is like scaffolding for the cell wall.
It holds in place a number of other proteins which all help the cell wall
work properly. Without dystrophin the
cell wall disintegrates. Secondly, dystrophin
is like a shock absorber. It is long and
springy. This enables muscle cells to
absorb impact without getting damaged.
People
with DMD do not have any dystrophin in their muscle cells.
Why do people
with DMD lack dystrophin?
In
every cell of the body there is a chemical ‘instruction book’ called DNA. The chemicals of DNA act just like letters
and words. DNA contains instructions for
the body to make everything it needs to grow and to maintain itself, including
dystrophin and thousands of other proteins.
Each DNA ‘word’ is three ‘letters’ or chemicals long.
DNA
has twenty two ‘chapters’, or chromosomes.
Each person has two copies of each of these chromosomes in every cell. There are also two further chromosomes,
called X and Y. Women have two copies of
the X chromosome and no Y chromosome.
Men have one X chromosome and one Y chromosome.
The
DNA instruction for dystrophin is in the X chromosome.
The
instruction for making dystrophin (or any other protein) is a bit like the
instruction for building a tower out of Lego bricks. You can imagine it like this:
Start with blue brick then green
brick then blue brick then
red brick yellow brick red brick yellow brick red
brick yellow brick
red brick yellow brick red brick yellow brick red
brick yellow brick
red brick yellow brick red brick yellow brick red
brick yellow brick
blue brick green brick blue brick.
No
problem. But sometimes there is a ‘mistake’
or mutation, and the instruction is unreadable.
Letters or words can be repeated, or missed out, as in this example:
Start with blue brick then green
brick then blue brick then
rbr ickye llowbr ickre dbr ickye
llowbr ickre dbr ickye llowbr ickre
dbr ickye llowbr ickre dbr ickye llowbr ickre dbr
ickye llowbr ickre
dbr ickye
llowbr ickre dbr ickye llowbr ickre dbr ickye llowbr ickbl
uebr ickgr eenbr ickbl uebr ick.
Here,
two letters have been missed out. The
other letters have shunted up, in the place of the missing letters. The result is gobbledegook.
Sometimes
there can be a full stop before the instruction has finished, as in this
example:
Start with blue brick then green
brick then blue brick then
red.
The body reads up to the full stop, and the
result is a truncated protein which won’t work.
If
the body can’t read the instruction and can’t make dystrophin, the muscle cell
dies. Over time that means progressive
loss of muscle tissue. Muscle is
replaced by scarring and fatty tissue.
What I have outlined here are the kinds of
mutation that can occur in DNA instructions.
In about 85 – 90% of DNA mutations, letters are missed out or
added. In about 10 – 15% of mistakes, full
stops are put in before the end of the instruction. .
Mutations
can happen anywhere in the DNA instruction book. Depending on where they are they cause
different conditions. Haemophilia,
cystic fibrosis, some forms of sight loss, and predisposition to certain
cancers are all examples of conditions caused by DNA mutations.
The
body does have a back-up plan. Every
cell contains two full copies of 22 chromosomes. Girls also get two X chromosomes. If there is a mutation on one, the body can
use the other. However, boys only get
one copy of the X chromosome. The Y chromosome
contains instructions for making testicles, but it doesn’t contain the
instructions that are in chapter X for making dystrophin and some other crucial
proteins. That is why it is usually only
boys who get Duchenne muscular dystrophy.
How are scientists tackling Duchenne
muscular dystrophy?
Scientists
are exploring a number of ways to treat Duchenne muscular dystrophy and turn it
into a manageable condition. There are
four main approaches to tackling the condition.
The four approaches are outlined here, along with the main lines of
research which use each approach. The examples
are not exhaustive
Correct the
body’s reading of the DNA mutation
Exon
skipping: this targets DNA instructions which have been
turned into gobbledegook. It cuts letters
out of the faulty instruction so that the letters get back in the right
place. In the example given earlier, you
could cut the underlined letters to restore a readable instruction:
Start with blue brick then green brick then blue brick
then
rbr ickye llowbr ickre dbr
ickye llowbr ickre dbr ickye llowbr ickre
dbr ickye llowbr ickre dbr ickye llowbr ickre dbr
ickye llowbr ickre
dbr ickye
llowbr ickre dbr ickye llowbr ickre dbr ickye llowbr ickbl
uebr ickgr eenbr ickbl uebr ick.
If
you cut these letters you would not get full dystrophin, but it would
work. Duchenne muscular dystrophy would
become a milder condition called Becker muscular dystrophy: there would still be some loss of muscle, but
Becker is usually much less severe and life-shortening than DMD.
Translarna: this is a drug which targets premature full
stops. It aims to enable the body to
‘read through’ the premature full stop. In
cases of premature full stops, the rest of the instruction is there, but the
body does not read it because it stops at the full stop. Translarna could potentially restore
full-length dystrophin.
Bring in
dystrophin from outside the body
Adeno-associated
virus vectors (AAV): this approach uses
empty virus ‘shells’ to bring dystrophin into the body and transport it to
every muscle cell.
A
difficulty here is that dystrophin is very big indeed, as you would expect of a
protein which is a cell wall scaffolding and shock absorber – too big to fit
into viruses without being modified. So
researchers are looking at two solutions: dividing the dystrophin into three
parts, each transported by a virus; and using ‘micro-dystrophin’ – finding the
optimal version of dystrophin which has all the essential parts but some of the
middle ‘springy’ bits left out, a version which would produce the mildest
possible symptoms of Becker muscular dystrophy.
Replace
dystrophin with another protein/ways to hold the cell wall together
Utrophin is a protein which does the
same job as dystrophin at the foetal stage and shortly after birth. The body then switches it off. Researchers are developing a drug to enable
the body to keep utrophin switched on and boosted up, to replace the missing
dystrophin.
Ways to
prolong strength or build up muscle to compensate for muscle loss
Steroids are currently used to help
prolong muscle strength. They do have
some effect, on average prolonging ambulation by an average of 2 to 4.5 years
depending on when they are started and the dose. However, they can’t boost up muscle strength
to anywhere near the level needed and they have a lot of adverse side effects.
Myostatin
inhibitors: myostatin is a substance in the body which
stops it from making too much muscle. If
myostatin could be switched off or inhibited, the body would make more muscle, potentially
enough to compensate for the continuous muscle loss in DMD.
Stem
cells: these are cells in the body with the
potential to turn into any kind of cell.
It might be possible to direct stem cells to turn into muscle cells.
No comments:
Post a Comment